Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-20

Clinical Trial Update: High-dose ICE With Amifostine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose ICE chemotherapy with Amifostine has completed accrual and results are reported for multiple solid tumors, including bladder …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amifostine (amifostine)
  • CARBOPLATIN (Carboplatin)
  • Etoposide (Etoposide)
  • IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Bladder Cancer, Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED